All Stories

  1. Impact of Multiple Sclerosis Subtypes on Pain Management in Patients With Trigeminal Neuralgia After Stereotactic Radiosurgery: An International Multicenter Analysis
  2. Clinical outcomes following stereotactic radiosurgery for cerebral cavernous malformations of the basal ganglia and thalamus
  3. Local control and survival after stereotactic radiosurgery for colorectal cancer brain metastases: an international multicenter analysis
  4. Stereotactic radiosurgery in the management of non–small cell lung cancer brain metastases: a prospective study using the NeuroPoint Alliance Stereotactic Radiosurgery Registry
  5. Selected-Lesion Stereotactic Radiosurgery (SL-SRS) as a Novel Strategy in the Treatment of Patients With Multiple Brain Metastases
  6. Stereotactic radiosurgery for haemorrhagic cerebral cavernous malformation: a multi-institutional, retrospective study
  7. Clinical and Imaging Outcomes After Trigeminal Schwannoma Radiosurgery: Results From a Multicenter, International Cohort Study
  8. Silent Corticotroph Staining Pituitary Neuroendocrine Tumors: Prognostic Significance in Radiosurgery
  9. Epilepsy associated with cerebral cavernous malformations managed with stereotactic radiosurgery: an international, multicenter study
  10. Local Control and Survival Outcomes After Stereotactic Radiosurgery for Brain Metastases From Gastrointestinal Primaries: An International Multicenter Analysis
  11. Treatment of adverse radiation effects with Boswellia serrata after failure of pentoxifylline and vitamin E: illustrative cases
  12. Stereotactic Radiosurgery for Intraventricular Metastases: A Multicenter Study
  13. Adjuvant versus on-progression Gamma Knife radiosurgery for residual nonfunctioning pituitary adenomas: a matched-cohort analysis
  14. Factors associated with progression and mortality among patients undergoing stereotactic radiosurgery for intracranial metastasis: results from a national real-world registry
  15. Stereotactic radiosurgery for glioblastoma considering tumor genetic profiles: an international multicenter study
  16. Stereotactic radiosurgery for the treatment of hypoglossal schwannoma: a multi-institutional retrospective study
  17. Stereotactic radiosurgery for IDH wild type glioblastoma: an international, multicenter study
  18. Dose to neuroanatomical structures surrounding pituitary adenomas and the effect of stereotactic radiosurgery on neuroendocrine function: an international multicenter study
  19. Clinical and radiologic outcomes after stereotactic radiosurgery for meningiomas in direct contact with the optic apparatus: an international multicenter study
  20. Stereotactic radiosurgery for clinoid meningiomas: a multi-institutional study
  21. Stereotactic Radiosurgery for Olfactory Groove Meningiomas: An International, Multicenter Study
  22. Treatment of WHO Grade 2 Meningiomas With Stereotactic Radiosurgery: Identification of an Optimal Group for SRS Using RPA
  23. Local failure after stereotactic radiosurgery (SRS) for intracranial metastasis: analysis from a cooperative, prospective national registry
  24. Stereotactic Radiosurgery for Perioptic Meningiomas: An International, Multicenter Study
  25. Stereotactic Radiosurgery for Atypical (World Health Organization II) and Anaplastic (World Health Organization III) Meningiomas: Results From a Multicenter, International Cohort Study
  26. Stereotactic radiosurgery for treatment of radiation-induced meningiomas: a multiinstitutional study
  27. Stereotactic radiosurgery with versus without prior Onyx embolization for brain arteriovenous malformations
  28. Stereotactic Radiosurgery With Versus Without Embolization for Brain Arteriovenous Malformations
  29. Embolization of Brain Arteriovenous Malformations With Versus Without Onyx Before Stereotactic Radiosurgery
  30. Earlier radiosurgery leads to better pain relief and less medication usage for trigeminal neuralgia patients: an international multicenter study
  31. Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases
  32. Quality of life outcomes for brain metastasis patients treated with stereotactic radiosurgery: pre-procedural predictive factors from a prospective national registry
  33. Role of Gamma Knife Radiosurgery in Small Cell Lung Cancer: A Multi-Institutional Retrospective Study of the International Radiosurgery Research Foundation (IRRF)
  34. Stereotactic Radiosurgery for Neurosurgical Patients: A Historical Review and Current Perspectives
  35. Ventricular violation increases the risk of leptomeningeal disease in cavity-directed radiosurgery treated patients
  36. Commentary: Stereotactic Radiosurgery Training for Neurosurgery Residents: Results of a Survey of Residents, Attendings, and Program Directors by the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors
  37. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily
  38. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
  39. BRAF V600 Mutation and BRAF Kinase Inhibitors in Conjunction With Stereotactic Radiosurgery for Intracranial Melanoma Metastases: A Multicenter Retrospective Study
  40. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas
  41. Oncogenic Signaling Pathways in The Cancer Genome Atlas
  42. A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
  43. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
  44. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
  45. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
  46. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
  47. Genomic and Functional Approaches to Understanding Cancer Aneuploidy
  48. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas
  49. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types
  50. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers
  51. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
  52. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
  53. Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
  54. Debulking surgery of pituitary adenoma as a strategy to facilitate definitive stereotactic radiosurgery
  55. Medulloblastoma in adults
  56. EXTH-47. DEVELOPMENT OF NANOFIBER-BASED CONTROLLED LOCAL DRUG DELIVERY AS A NOVEL ADJUVANT MODALITY FOR TREATMENT OF GLIOBLASTOMA
  57. A rare case of central nervous system amyloidoma treated with fractionated radiotherapy
  58. Radioactive seed migration in the brain
  59. Debulking Surgery of Pituitary Adenoma as a Strategy to Facilitate Definitive Stereotactic Radiosurgery: A Retrospective Review
  60. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
  61. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
  62. International Differences in Treatment and Clinical Outcomes for High Grade Glioma
  63. CN-13 * RECURRENT ASEPTIC MENINGITIS IN PATIENTS WITH METASTATIC BRAIN TUMORS; A NOVEL PERSPECTIVE
  64. NT-06 * PHOSPHATIDYLSERINE-SELECTIVE TARGETING AND ANTICANCER EFFECTS OF SapC-DOPS NANOVESICLES ON BRAIN TUMORS
  65. Target definition for malignant gliomas: No difference in radiation treatment volumes between 1.5T and 3T magnetic resonance imaging
  66. Whole genome sequencing of glioblastoma multiforme identifies multiple structural variations involved in EGFR activation
  67. Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors
  68. Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK
  69. Methylation markers of malignant potential in meningiomas
  70. The brain microenvironment negatively regulates miRNA-768-3p to promote K-ras expression and lung cancer metastasis
  71. Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients
  72. Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas
  73. Abstract LB-277: Microenvironment-induced changes in miRNA levels promote brain metastasis, drug resistance and KRA expression.
  74. Patient Selection for Anti-Egfviii Therapies in Glioblastoma Multiforme (GBM): Use of Circulating Tumor DNA
  75. Measuring surgical outcomes in neurosurgery: implementation, analysis, and auditing a prospective series of more than 5000 procedures
  76. Results of phase I study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy
  77. Management strategies after nondiagnostic results with frameless stereotactic needle biopsy: Retrospective review of 28 patients
  78. Family History of Cancer in Benign Brain Tumor Subtypes Versus Gliomas
  79. Irradiated Volume as a Predictor of Brain Radionecrosis After Linear Accelerator Stereotactic Radiosurgery
  80. Comparing the risks of frameless stereotactic biopsy in eloquent and noneloquent regions of the brain: a retrospective review of 284 cases
  81. Evaluation of Image-Guided Positioning for Frameless Intracranial Radiosurgery
  82. Frameless Image-Guided Intracranial Stereotactic Radiosurgery: Clinical Outcomes for Brain Metastases
  83. Management of newly diagnosed single brain metastasis with surgical resection and permanent I-125 seeds without upfront whole brain radiotherapy
  84. Intracranial Treatment for Solitary Prostatic Adenocarcinoma Brain Metastasis is Curative
  85. Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme
  86. Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two-institution experience
  87. GNOSIS: Guidelines for Neuro-Oncology: Standards for Investigational Studies — reporting of surgically based therapeutic clinical trials
  88. Resident training in neurosurgical oncology: results of the survey of North American training programs by the AANS/CNS Section on Tumors
  89. Adaptation of a standard low-field (0.3-T) system to the operating room: focus on pituitary adenomas
  90. Stereotactic Radiosurgery for Patients with Solid Brain Metastases: Current Status
  91. Results of Contemporary Surgical Management of Radiation Necrosis using Frameless Stereotaxis and Intraoperative Magnetic Resonance Imaging
  92. Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma
  93. Local convection enhanced delivery of IL4-Pseudomonas exotoxin (NBI-3001) for treatment of patients with recurrent malignant glioma
  94. Tumor Resection in a Shared-Resource Magnetic Resonance Operating Room: Experience at the University of Cincinnati
  95. Clinical Experience with a Shared-Resource, Intraoperative Magnetic Resonance Imaging Center for Resection of Intracranial Neoplasms
  96. Management Strategy for Adult Patients with Dorsal Midbrain Gliomas
  97. Intraoperative Magnetic Resonance Imaging to Determine the Extent of Resection of Pituitary Macroadenomas during Transsphenoidal Microsurgery
  98. Distant Wounded Glioma Syndrome: Report of Two Cases
  99. Glioma Resection in a Shared-resource Magnetic Resonance Operating Room after Optimal Image-guided Frameless Stereotactic Resection
  100. Permanent Iodine-125 Interstitial Implants for the Treatment of Recurrent Glioblastoma Multiforme
  101. Clonal Origin of Recurrent Meningiomas
  102. A Syngeneic Mouse Glioma Model for Study of Glioblastoma Therapy
  103. Functional outcome of inpatient rehabilitation in persons with brain tumors
  104. A simple, reproducible technique for establishing leptomeningeal tumors in nude rats
  105. Neurosurgical Outcomes in a Modern Series of 400 Craniotomies for Treatment of Parenchymal Tumors
  106. Radiation Therapy and Hydroxyurea Followed by the Combination of 6-Thioguanine and BCNU for the Treatment of Primary Malignant Brain Tumors
  107. Corpus Callosal Changes Associated with Hydrocephalus: A Report of Two Cases
  108. A Novel Multiply-Mutated HSV-1 Strain for the Treatment of Human Brain Tumors
  109. Stereotactic radiosurgery for the treatment of brain metastases
  110. Intravenous Carboplatin for Recurrent Gliomas
  111. Role of genomic instability in meningioma progression
  112. Role of genomic instability in meningioma progression
  113. Protein and messenger RNA expression of connexin43 in astrocytomas: implications in brain tumor gene therapy
  114. A Method to Reduce Systematic Spatial Shift Associated with Magnetic Resonance Imaging
  115. Expression of N-cadherin and α-catenin in astrocytomas and glioblastomas
  116. Medulloblastoma in adults
  117. Measurement of vascular permeability in spinal cord using Evans Blue spectrophotometry and correction for turbidity
  118. Identification and partial sequence of a cDNA that is differentially expressed in human brain tumors
  119. RNA expression of complement regulatory proteins in human brain tumors
  120. A phase II study of intravenous carboplatin for the treatment of recurrent gliomas
  121. In VitroEvidence That Metabolic Cooperation Is Responsible for the Bystander Effect Observed with HSVtkRetroviral Gene Therapy
  122. Intracranial myxopapillary ependymoma: Case report
  123. Intradural chordoma of the tentorium cerebelli
  124. In Vivo Metabolism of Radiolabeled Putrescine in Gliomas: Implications for Positron Emission Tomography of Brain Tumors